Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 13:45:31 GMT 2023
by
admin
on
Sat Dec 16 13:45:31 GMT 2023
|
| Protein Type | BISPECIFIC ANTIBODY |
| Protein Sub Type | IGG1 |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
0JSR7Z0NB6
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Related Record | Type |
|---|
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1454
Created by
admin on Sat Dec 16 13:45:31 GMT 2023 , Edited by admin on Sat Dec 16 13:45:31 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
0JSR7Z0NB6
Created by
admin on Sat Dec 16 13:45:31 GMT 2023 , Edited by admin on Sat Dec 16 13:45:31 GMT 2023
|
PRIMARY | |||
|
C124993
Created by
admin on Sat Dec 16 13:45:31 GMT 2023 , Edited by admin on Sat Dec 16 13:45:31 GMT 2023
|
PRIMARY | |||
|
Amivantamab
Created by
admin on Sat Dec 16 13:45:31 GMT 2023 , Edited by admin on Sat Dec 16 13:45:31 GMT 2023
|
PRIMARY | |||
|
2549199
Created by
admin on Sat Dec 16 13:45:31 GMT 2023 , Edited by admin on Sat Dec 16 13:45:31 GMT 2023
|
PRIMARY | |||
|
0JSR7Z0NB6
Created by
admin on Sat Dec 16 13:45:31 GMT 2023 , Edited by admin on Sat Dec 16 13:45:31 GMT 2023
|
PRIMARY | |||
|
11030
Created by
admin on Sat Dec 16 13:45:31 GMT 2023 , Edited by admin on Sat Dec 16 13:45:31 GMT 2023
|
PRIMARY | |||
|
2171511-58-1
Created by
admin on Sat Dec 16 13:45:31 GMT 2023 , Edited by admin on Sat Dec 16 13:45:31 GMT 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_152 | 1_208 |
| 1_228 | 3_214 |
| 1_234 | 2_228 |
| 1_237 | 2_231 |
| 1_269 | 1_329 |
| 1_375 | 1_433 |
| 2_22 | 2_96 |
| 2_146 | 2_202 |
| 2_222 | 4_214 |
| 2_263 | 2_323 |
| 2_369 | 2_427 |
| 3_23 | 3_88 |
| 3_134 | 3_194 |
| 4_23 | 4_88 |
| 4_134 | 4_194 |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_305 |
| N | 2_299 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
BINDING
Kd
|
||
|
TARGET -> INHIBITOR |
BINDING
Kd
|
||
|
INHIBITOR -> TARGET |
Approved for treatment of EGFR EXON 20 insertions mutations in NSLC
|
||
|
SUB_CONCEPT->SUBSTANCE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|